The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of 177Lu-PSMA radionuclide treatment in patients with diffuse bone marrow involvement: A multicenter retrospective study.
 
Andrei Gafita
No Relationships to Disclose
 
Wolfgang Peter Fendler
Consulting or Advisory Role - Endocyte; Ipsen; RadioMedix
 
Hui Wang
No Relationships to Disclose
 
Shahneen Kaur Sandhu
Honoraria - Amgen; Bristol-Myers Squibb; Merck; Merck Serono
Consulting or Advisory Role - Amgen
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche/Genentech
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Manuel Weber
No Relationships to Disclose
 
Rouzbeh Esfandiari
No Relationships to Disclose
 
Johannes Czernin
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Advanced Accelerator Applications
 
Hendrik Rathke
No Relationships to Disclose
 
Isabel Rauscher
No Relationships to Disclose
 
Robert Tauber
No Relationships to Disclose
 
Ebrahim Delpassand
Employment - Radiomedix
Stock and Other Ownership Interests - Endocyte; Radiomedix
Honoraria - Advanced Accelerator Applications/Novartis; Endocyte
Consulting or Advisory Role - Endocyte
Speakers' Bureau - Advanced Accelerator Applications/Novartis; Bayer
Patents, Royalties, Other Intellectual Property - Curium Pharma. Licensing Agreement. (Inst)
Travel, Accommodations, Expenses - Endocyte
 
Wolfgang A Weber
No Relationships to Disclose
 
Ken Herrmann
No Relationships to Disclose
 
Jeremie Calais
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Chimerix; Clovis Oncology; Endocyte; Progenics
Honoraria - Progenics; Radiomedix
Consulting or Advisory Role - Blue Earth Diagnostics; Janssen
 
Matthias Eiber
Consulting or Advisory Role - ABX Advanced biochemical compounds; Blue Earth Diagnostics
Research Funding - ABX Advanced biochemical compounds; Blue Earth Diagnostics; Siemens
Patents, Royalties, Other Intellectual Property - patent application for rhPSMA
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Michael S Hofman
Consulting or Advisory Role - Endocyte; Janssen
Research Funding - Endocyte (Inst)
Travel, Accommodations, Expenses - Genzyme; Ipsen; Janssen